Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AG (OTCPK:MKLNF) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
M1 Kliniken AG Forward PE Ratio Related Terms
M1 Kliniken AG Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG Forward PE Ratio Chart
M1 Kliniken AG Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
11.62
8.54
M1 Kliniken AG Semi-Annual Data
2024-12
2025-06
2025-12
Forward PE Ratio
11.62
11.91
8.54
MKLNF vs MCK, CAH, COR: Forward PE Ratio Comparison
For the Medical Distribution subindustry, M1 Kliniken AG's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG Forward PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
M1 Kliniken AG (MKLNF) has a Forward PE Ratio of 9.63 as of Jul. 25, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on M1 Kliniken AG and its competitors. According to the industry distribution chart, M1 Kliniken AG ranks #35 out of 51 companies in the Medical Distribution industry, placing it in the top 68.6%.
Is M1 Kliniken AG's Forward PE Ratio too high?
M1 Kliniken AG's current Forward PE Ratio is 9.63. The Medical Distribution industry median Forward PE Ratio is 14.62. M1 Kliniken AG's value of 9.63 is 34.1% below this industry median. Based on the distribution chart, M1 Kliniken AG ranks #35 out of 51 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, M1 Kliniken AG has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's Forward PE Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #35 out of 51 companies for Forward PE Ratio. This places M1 Kliniken AG in the lower half of its industry. The industry median Forward PE Ratio is 14.62. M1 Kliniken AG's value of 9.63 is 34.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 14.62, based on 51 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current Forward PE Ratio of 9.63 is 34.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 14.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current Forward PE Ratio is 9.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current Forward PE Ratio of 9.63. The stock's GF Value™ is $10.20, compared to a current price of $11.73 — trading 15% above its estimated fair value. The current Forward PE Ratio is 9.63 and 34.1% below the Medical Distribution industry median of 14.62. M1 Kliniken AG's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current Forward PE Ratio is 9.63 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 15% above its estimated GF Value™ of $10.20.
Key valuation signals for MKLNF:
Forward PE Ratio: 9.63
GF Value™: $10.20 vs. price of $11.73 (15% above fair value)
Industry Position: 34.1% below the Medical Distribution median (#35 of 51)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
93GF Score
Get the complete analysis for MKLNF
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
